Table 1.
Control type | Cell or organism models | Edited gene | Key molecule / structure | Ref. |
---|---|---|---|---|
Modular CRISPR fusion system | MSC, HEK-293T, hPSC; yeast cell, HeLa cell | adipogenic genes, human ASCL1, IL1RN, ZFP42 and OCT4 genes, pluripotency gene NANOG, GFP reporter gene | VP64, p65, copies of VP16, VP64-p65-Rta tripartite, multiple sgRNAs, AcrIIA1-4, KRAB, SID4X | 31,32,38,39,41–45,48,60 |
Cell-specific promoter | Huh7 cell, HEK-293T cell, HepG2.2.15 cell, mouse T cell, B cell, neutrophil, monocyte, macrophage, and spleen cell, zebrafish, C. elegans | hepatitis B virus (HBV) genome, mouse CD2 gene, macrophage-specific gene sgNtn 1, zebrafish urod gene, C. elegans somatic cell DPY-5, LON-2, and GFP gene | liver-specific promoter, macrophage-specific promoter, CD4 promoter, erythrocyte-specific gata1 promoter, Egg cell-specific promoter | 37,52–55,57 |
MSC mesenchymal stem cell, HEK-293T cell human embryonic kidney 293T cell, hPSC human pluripotent stem cell, Huh7 cell human liver cancer cell line, GFP green fluorescent protein, VP64, p65, VP16 and Rta transcription activation domains, KRAB, SID4X, MXl1 and WRPW transcription repression domain